Faculty News

Professor Aswath Damodaran's research on pharmaceutical companies' profit margins is cited

The Economist logo
Excerpt from The Economist -- "According to a recent study by Aswath Damodaran of New York University’s Stern School of Business, on this basis drug firms’ margins are 24%, higher than most other sectors (see chart)."

Read more